A Myeloma UK Infopack for carers of myeloma patients has been Highly Commended in the 2017 British Medical Association (BMA) […]
The seasonal influenza (flu) vaccination is now available from your GP practice. It is recommended that myeloma patients are vaccinated […]
Myeloma UK has crowned its Myeloma Academy SharkTank 2017 winner as Dr Jonathan Carmichael, a Myeloma Clinical Research Fellow working […]
Myeloma UK-funded researchers at The Institute of Cancer Research have published new research into how studying specific genetic abnormalities in myeloma cells to help create more targeted and effective treatments.
University Hospitals of North Midlands NHS Trust (UHNM) is the latest organisation to join the Myeloma UK Clinical Trial Network (CTN), which aims to help patients access the latest, innovative myeloma treatments.
Patient and Myeloma UK regular donor Nick Argent explains why he’s backing our new Direct Debit campaign.
Learn more about our very first Myeloma UK Infoday designed exclusively for carers, family and friends of myeloma patients, which received outstanding feedback from attendees.
Our Health Services Research Manager, Dr Jayne Galinsky, talks about presenting Myeloma UK’s research on patient treatment preferences at two major clinical conferences held recently in Rome and Madrid.
Discover how Myeloma UK is working in partnership with a group of key myeloma and healthcare professionals to improve diagnosis rates for myeloma patients.